The Company’s available-for-sale securities as of March 31, 2026 and December 31, 2025 are summarized below (in thousands): | | | | | | | | | | | | | | | Cost | | Unrealized Gains in
Investment Income | | Unrealized
Losses in
Investment Income | | Estimated
Fair Value
(Level 1 Inputs) | March 31, 2026 | | | | | | | | | | | | | Common Stock | | $ | 22,486 | | $ | — | | $ | (27) | | $ | 22,459 | Operating Units | | | 23,253 | | | — | | | (1,224) | | | 22,029 | Total Equity Securities | | $ | 45,739 | | $ | — | | $ | (1,251) | | $ | 44,488 | | | | | | | | | | | | | | December 31, 2025 | | | | | | | | | | | | | Common Stock | | $ | 22,486 | | $ | — | | $ | (1,625) | | $ | 20,861 | Operating Units | | | 23,253 | | | — | | | (2,790) | | | 20,463 | Total Equity Securities | | $ | 45,739 | | $ | — | | $ | (4,415) | | $ | 41,324 |
|